3.0(top 20%)
impact factor
17.1K(top 1%)
papers
798.7K(top 1%)
citations
262(top 1%)
h-index
3.1(top 20%)
impact factor
17.9K
all documents
826.2K
doc citations
399(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1The tail suspension test: A new method for screening antidepressants in micePsychopharmacology19852,834
2The use of a plus-maze to measure anxiety in the mousePsychopharmacology19872,130
3The debate over dopamine’s role in reward: the case for incentive saliencePsychopharmacology20071,919
4Varieties of impulsivityPsychopharmacology19991,643
5Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressantPsychopharmacology19871,630
6Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluationPsychopharmacology19971,607
7Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studiesPsychopharmacology20011,562
8The reinstatement model of drug relapse: history, methodology and major findingsPsychopharmacology20031,484
9Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in reviewPsychopharmacology20011,404
10Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuliPsychopharmacology19991,358
11How does stress increase risk of drug abuse and relapse?Psychopharmacology20011,290
12Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studiesPsychopharmacology19971,283
13Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studiesPsychopharmacology20001,251
14Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressantsPsychopharmacology19951,239
15The validity of animal models of depressionPsychopharmacology19841,197
16The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistryPsychopharmacology20021,155
17Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokersPsychopharmacology19991,148
18Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mousePsychopharmacology19681,140
19Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significancePsychopharmacology20061,113
20Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor bindingPsychopharmacology19961,065
21Conditioned place preference: what does it add to our preclinical understanding of drug reward?Psychopharmacology20001,057
22Affective neuroscience of pleasure: reward in humans and animalsPsychopharmacology20081,011
23Effects of early life stress on cognitive and affective function: an integrated review of human literaturePsychopharmacology2011995
24Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challengesPsychopharmacology2001969
25Tonic dopamine: opportunity costs and the control of response vigorPsychopharmacology2007969
26Mode of action of apomorphine and dexamphetamine on gnawing compulsion in ratsPsychopharmacology1967924
27Effort-related functions of nucleus accumbens dopamine and associated forebrain circuitsPsychopharmacology2007913
28Reinstatement of cocaine-reinforced responding in the ratPsychopharmacology1981900
29Is the forced swimming test a suitable model for revealing antidepressant activity?Psychopharmacology1988886
30Delineation of two drug-responsive anxiety syndromesPsychopharmacology1964866
31A simple and reliable conflict procedure for testing anti-anxiety agentsPsychopharmacology1971789
32Forced swimming test in mice: a review of antidepressant activityPsychopharmacology2005788
33Delayed reward discounting and addictive behavior: a meta-analysisPsychopharmacology2011782
34Self-administration of psychoactive substances by the monkeyPsychopharmacology1969781
35Measures of impulsivity in cigarette smokers and non-smokersPsychopharmacology1999777
36The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the ratPsychopharmacology1960776
37The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotinePsychopharmacology1992767
38Induction of physical dependence upon ethanol and the associated behavioral changes in ratsPsychopharmacology1975718
39Endogenous opioid systems and alcohol addictionPsychopharmacology1997715
40Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localizationPsychopharmacology2006711
41Guidelines on nicotine dose selection for in vivo researchPsychopharmacology2007694
42Tryptophan depletion causes a rapid lowering of mood in normal malesPsychopharmacology1985678
43Ionotropic and metabotropic glutamate receptor structure and pharmacologyPsychopharmacology2005663
44The role of impulsive behavior in drug abusePsychopharmacology2008654
45Nicotinic acetylcholine involvement in cognitive function in animalsPsychopharmacology1998646
46Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controlsPsychopharmacology2001646
47Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effectsPsychopharmacology2011638
48l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunctionPsychopharmacology1992631
49Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in ratsPsychopharmacology1984621
50Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxietyPsychopharmacology1994611